Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1152 Results

Title
Intervention Indication Therapeutic Area Year Actions
Bempedoic acid (monotherapy) or bempedoic acid in combination with ezetimibe for primary hypercholesterolaemia or mixed dyslipidaemia Bempedoic acid (ETC-1002; Nilemdo) , Ezetimibe (Ezetrol; MK-0653) Mixed dyslipidaemia , Primary hypercholesterolaemia Endocrine Nutritional and Metabolic Disorders 2018 View  |  Download
Bempedoic acid (monotherapy) and bempedoic acid/ezetimibe (fixed-dose combination) for primary hypercholesterolaemia or mixed dyslipidaemia Bempedoic acid (ETC-1002; Nilemdo) , Ezetimibe (Ezetrol; MK-0653) Mixed dyslipidaemia , Primary hypercholesterolaemia Endocrine Nutritional and Metabolic Disorders 2018 View  |  Download
Belzutifan for von Hippel-Lindau disease-associated clear cell renal cell carcinoma – first line Belzutifan (PT2977; MK-6482) Renal cell carcinoma (RCC) Genetic Disorders , Oncology , Renal Cancer 2021 View  |  Download
Belzutifan for advanced or metastatic clear cell renal cell carcinoma after 1 therapy Belzutifan (PT2977; MK-6482) Renal cell carcinoma (RCC) Renal Cancer 2022 View  |  Download
Belumosudil for graft versus host disease Belumosudil (SLx-2119; KD025; KD-025) Graft versus host disease (GvHD) Immunology 2021 View  |  Download
Belinostat (Beleodaq) with CHOP for treatment of patients with peripheral T‐cell lymphoma, 1st line Belinostat (Beleodaq; PXD101) , CHOP Peripheral T-cell lymphoma (PTCL) Haematological Cancer and Lymphomas 2017 View  |  Download
Belimumab in combination with rituximab for systemic lupus erythematosus (SLE) Belimumab (Benlysta; Lymphostat-B) , Rituximab (MabThera; Rituxan; RG 105) Systemic lupus erythematosus (SLE) Immunology , Nephrology 2021 View  |  Download
Belimumab for lupus nephritis Belimumab (Benlysta; Lymphostat-B) Lupus nephritis Immunology , Nephrology 2019 View  |  Download
Belimumab (subcutaneous injection) add-on for systemic lupus erythematosus in children aged 5 to 17 years old Belimumab (Benlysta; Lymphostat-B) Systemic lupus erythematosus (SLE) Immunology , Nephrology 2022 View  |  Download
Belantamab mafodotin with pomalidomide and dexamethasone for previously treated relapsed/refractory multiple myeloma Belantamab mafodotin (GSK2857916; anti-BCMA-ADC) , Dexamethasone (dexamethasone sodium metasulfobenzoate) , Pomalidomide (Imnovid; CC-4047; Pomalyst) Multiple myeloma (MM) Haematological Cancer and Lymphomas 2022 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications